Neuropeptide Y reduces expression of social fear via simultaneous activation of Y1 and Y2 receptors.

These findings have important clinical implications, as they suggest that although medication strategies aimed at increasing brain NPY activity are unlikely to prevent the formation of aversive memories after a traumatic social experience, they might improve the recovery from a traumatic social experience by reducing the expression of social fear.